Dr. Robin Brese focuses her practice on the development and management of global patent portfolios for clients in the life science, biotechnology, pharmaceutical, and agricultural industries. Her practice includes preparing and prosecuting patent applications and providing clients with strategic patent counseling. She also advises clients on matters related to patent landscapes, freedom-to-operate, patentability, and due diligence evaluations.
Robin leverages her broad scientific background to represent clients on a variety of technologies including immunotherapies (e.g., therapeutic antibodies), gene therapies, nucleic acids, antibody platforms, recombinant proteins, engineered cells, small molecules, and devices.
Robin holds a Ph.D. in immunology and virology from the University of Massachusetts Medical School. Her thesis research focused on characterizing the tissue compartmentalization and tropism of HIV-1 populations in AIDS patients with antiretroviral drug failure and provided new deep sequencing tools for studying viral variants.
In addition, Robin earned an M.S. in plant biology from the University of New Hampshire and has research experience in plant pathology, genomics, and transgenics.
Prior to joining Jones Day, Robin was an associate in the Boston office of an international law firm. She also previously worked as a technical specialist and patent agent.
- Suffolk University (J.D. 2021); University of Massachusetts Medical School (Ph.D. in Immunology and Virology 2016); University of New Hampshire (M.S. in Plant Biology 2006); Wheaton College (B.A. in Environmental Science and Hispanic Studies 2003)
- Massachusetts and registered to practice before the United States Patent and Trademark Office